These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 30430296

  • 21. Targeting MmpL3 for anti-tuberculosis drug development.
    Bolla JR.
    Biochem Soc Trans; 2020 Aug 28; 48(4):1463-1472. PubMed ID: 32662825
    [Abstract] [Full Text] [Related]

  • 22. Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.
    Nataraj V, Varela C, Javid A, Singh A, Besra GS, Bhatt A.
    Mol Microbiol; 2015 Oct 28; 98(1):7-16. PubMed ID: 26135034
    [Abstract] [Full Text] [Related]

  • 23. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW, Walker JR, Alland D, Barry CE, Boshoff HI.
    Antimicrob Agents Chemother; 2012 Apr 28; 56(4):1797-809. PubMed ID: 22252828
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
    Kim S, Seo H, Mahmud HA, Islam MI, Kim YS, Lyu J, Nam KW, Lee BE, Lee KI, Song HY.
    J Microbiol Biotechnol; 2017 Nov 28; 27(11):1932-1941. PubMed ID: 28870005
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN, Dusthackeer VNA, Kumar MP, Nagarajan P, Sukumar S, Kumari VI, Lakshmi AR, Hanna LE.
    Tuberculosis (Edinb); 2017 Dec 28; 107():144-148. PubMed ID: 29050763
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.
    de Souza MV, Ferreira Mde L, Pinheiro AC, Saraiva MF, de Almeida MV, Valle MS.
    ScientificWorldJournal; 2008 Jul 31; 8():720-51. PubMed ID: 18677428
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis.
    Lemmer Y, Kalombo L, Pietersen RD, Jones AT, Semete-Makokotlela B, Van Wyngaardt S, Ramalapa B, Stoltz AC, Baker B, Verschoor JA, Swai HS, de Chastellier C.
    J Control Release; 2015 Aug 10; 211():94-104. PubMed ID: 26055640
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
    Bailo R, Bhatt A, Aínsa JA.
    Biochem Pharmacol; 2015 Aug 01; 96(3):159-67. PubMed ID: 25986884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.